Susan M. Fox

1.5k total citations
15 papers, 846 citations indexed

About

Susan M. Fox is a scholar working on Gastroenterology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Susan M. Fox has authored 15 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Gastroenterology, 10 papers in Surgery and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Susan M. Fox's work include Gastrointestinal motility and disorders (11 papers), Congenital gastrointestinal and neural anomalies (7 papers) and Gastroesophageal reflux and treatments (3 papers). Susan M. Fox is often cited by papers focused on Gastrointestinal motility and disorders (11 papers), Congenital gastrointestinal and neural anomalies (7 papers) and Gastroesophageal reflux and treatments (3 papers). Susan M. Fox collaborates with scholars based in United States, Israel and Ireland. Susan M. Fox's co-authors include Anthony Lembo, Mark G. Currie, Caroline B. Kurtz, Jeffrey M. Johnston, Steven J. Shiff, Xinwei D. Jia, Bernard J. Lavins, Paul Eng, Harvey Schneier and James E. MacDougall and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Susan M. Fox

14 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan M. Fox United States	9	664	522	135	79	65	15	846
Paul Eng United States	6	593 0.9×	430 0.8×	118 0.9×	73 0.9×	14 0.2×	7	751
Alfred D. Nelson United States	15	467 0.7×	381 0.7×	113 0.8×	33 0.4×	18 0.3×	33	761
Nonko Pehlivanov United States	12	613 0.9×	523 1.0×	111 0.8×	45 0.6×	14 0.2×	29	761
Kirsten Weiser United States	13	528 0.8×	367 0.7×	117 0.9×	81 1.0×	8 0.1×	22	761
G. P. Vanberge-Henegouwen Netherlands	18	458 0.7×	446 0.9×	204 1.5×	35 0.4×	34 0.5×	25	942
Christian Pehl Germany	18	507 0.8×	491 0.9×	77 0.6×	20 0.3×	9 0.1×	59	819
Daphne Ang Singapore	16	656 1.0×	646 1.2×	104 0.8×	20 0.3×	13 0.2×	48	853
Tetsuro Kawagoe Japan	14	467 0.7×	425 0.8×	45 0.3×	11 0.1×	17 0.3×	40	606
Kia Vosoughi United States	16	283 0.4×	378 0.7×	124 0.9×	25 0.3×	8 0.1×	38	681
Yolanda V. Scarlett United States	10	531 0.8×	543 1.0×	78 0.6×	55 0.7×	3 0.0×	19	918

Countries citing papers authored by Susan M. Fox

Since Specialization

Citations

This map shows the geographic impact of Susan M. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan M. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan M. Fox more than expected).

Fields of papers citing papers by Susan M. Fox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan M. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan M. Fox. The network helps show where Susan M. Fox may publish in the future.

Co-authorship network of co-authors of Susan M. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Susan M. Fox. A scholar is included among the top collaborators of Susan M. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan M. Fox. Susan M. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Chang, Lin, Brian E. Lacy, Baha Moshiree, et al.. (2021). Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System. The American Journal of Gastroenterology. 116(9). 1929–1937. 32 indexed citations

Chey, William D., Gregory S. Sayuk, Wilmin Bartolini, et al.. (2020). Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation. The American Journal of Gastroenterology. 116(2). 354–361. 17 indexed citations

Brenner, Darren M., Charles E. Argoff, Susan M. Fox, et al.. (2020). Efficacy and safety of linaclotide for opioid-induced constipation in patients with chronic noncancer pain syndromes from a phase 2 randomized study. Pain. 161(5). 1027–1036. 10 indexed citations

Chang, Lin, Brian E. Lacy, Baha Moshiree, et al.. (2020). Mo1550 A NOVEL SCORE TO EVALUATE ABDOMINAL SYMPTOM IMPROVEMENT IN PATIENTS WITH CONSTIPATION-PREDOMINANT IBS DEMONSTRATES EFFICACY OF LINACLOTIDE FOR IMPROVING ABDOMINAL BLOATING, DISCOMFORT, AND PAIN IN A PHASE 3B TRIAL. Gastroenterology. 158(6). S–891. 3 indexed citations

Nee, Judy, Jeffrey M. Johnston, Elizabeth P. Shea, et al.. (2019). Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis. Expert Review of Gastroenterology & Hepatology. 13(4). 397–406. 12 indexed citations

Schoenfeld, Philip, Brian E. Lacy, William D. Chey, et al.. (2017). Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. The American Journal of Gastroenterology. 113(1). 105–114. 55 indexed citations

Chey, William D., et al.. (2017). Effect of Linaclotide DR1, a Delayed-Release Formulation of Linaclotide, in IBS-C Patients: Analysis of Symptom Improvement Using Responder Radar Plots. The American Journal of Gastroenterology. 112. S236–S237. 1 indexed citations

Chey, William D., Paul Chamberlin, Wieslaw Bochenek, et al.. (2017). Targeted Delivery of Linaclotide to Specific Areas of The Intestine Affects Clinical Efficacy in Patients with Irritable Bowel Syndrome with Constipation (IBS-C). Gastroenterology. 152(5). S1314–S1315. 5 indexed citations

Lacy, Brian E., Ron Schey, Steven J. Shiff, et al.. (2015). Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial. PLoS ONE. 10(7). e0134349–e0134349. 56 indexed citations

10.

Lacy, Brian E., Anthony Lembo, Ron Schey, et al.. (2014). Sa2008 Efficacy and Safety of Linaclotide in Chronic Idiopathic Constipation Patients With Abdominal Bloating: Phase 3b Trial Results. Gastroenterology. 146(5). S–353. 1 indexed citations

11.

Rao, Satish S.C., Anthony Lembo, Steven J. Shiff, et al.. (2012). A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation. The American Journal of Gastroenterology. 107(11). 1714–1724. 293 indexed citations

12.

Lembo, Anthony, Harvey Schneier, Steven J. Shiff, et al.. (2011). Two Randomized Trials of Linaclotide for Chronic Constipation. New England Journal of Medicine. 365(6). 527–536. 270 indexed citations

13.

Kline‐Rogers, Eva, David Share, Diane Bondie, et al.. (2002). Development of a Multicenter Interventional Cardiology Database: The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Experience. Journal of Interventional Cardiology. 15(5). 387–392. 90 indexed citations

14.

Fox, Susan M.. (2002). Salivary cortisol and sleep disruption among early-stage breast cancer patients undergoing a stress management and relaxation training intervention.

15.

Gauvin, Gregory, et al.. (1987). Evaluation of the SYSMEX™ CC-800/PDA-410 System With Trimodal Histogram for White Cell Differential Analysis. Laboratory Medicine. 18(6). 373–381. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact